Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum
- PMID: 2509369
- PMCID: PMC259906
- DOI: 10.1128/iai.57.12.3788-3792.1989
Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum
Abstract
Differences in the 30-day survival of Histoplasma capsulatum after intravenous injection indicated that the A/J strain of inbred mouse was more resistant to experimental infection than was the C57BL/6 strain. CFU from the spleens of infected animals increased during the first week after injection but gradually declined over the next 3 weeks. The CFU per gram of tissue in the C57BL/6 animals were 10- to 100-fold higher than were those in the A/J mice during the time between 7 and 28 days after infection. The units of gamma interferon (IFN-gamma) in supernatants of spleen cells stimulated with heat-killed yeast cells of H. capsulatum reached a peak at the time of the largest number of CFU per gram of tissue. The titers of IFN-gamma at days 3 to 5 were higher in the A/J mice than they were in the C57BL/6 mice, but from days 7 to 28, the titers of IFN-gamma were not correlated with the more efficient clearance of the fungus from the spleens of A/J mice. The L3T4+ spleen cells were shown to be active IFN-gamma producers. Treatment of Histoplasma-infected mice with anti-IFN-gamma antibody resulted in much larger tissue burdens of the fungus in the lungs and spleens of treated animals than in untreated animals. There was no marked difference in the result of treatment with anti-IFN-gamma antibody between A/J and C57BL/6 mice. Treatment of Histoplasma-infected mice with recombinant murine IFN-gamma did not alter the course of infection in either inbred strain of mouse.
Similar articles
-
IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma.J Immunol. 1995 Jul 15;155(2):785-95. J Immunol. 1995. PMID: 7608555
-
Resistance mechanisms in murine experimental histoplasmosis.Arch Med Res. 1993 Autumn;24(3):233-8. Arch Med Res. 1993. PMID: 7905306 Review.
-
Role of L3T4+ T cells in host defense against Histoplasma capsulatum.Infect Immun. 1988 Jul;56(7):1685-91. doi: 10.1128/iai.56.7.1685-1691.1988. Infect Immun. 1988. PMID: 2968320 Free PMC article.
-
Histoplasma capsulatum and V beta a mice: cellular immune responses and susceptibility patterns.J Med Vet Mycol. 1993;31(3):181-8. J Med Vet Mycol. 1993. PMID: 8360809
-
Host response and Histoplasma capsulatum/macrophage molecular interactions.Med Mycol. 2000 Dec;38(6):399-406. doi: 10.1080/mmy.38.6.399.406. Med Mycol. 2000. PMID: 11204877 Review.
Cited by
-
Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.J Clin Invest. 2005 Oct;115(10):2875-85. doi: 10.1172/JCI25365. Epub 2005 Sep 8. J Clin Invest. 2005. PMID: 16151533 Free PMC article.
-
A deficiency in gamma interferon or interleukin-10 modulates T-Cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum.Infect Immun. 2005 Apr;73(4):2129-34. doi: 10.1128/IAI.73.4.2129-2134.2005. Infect Immun. 2005. PMID: 15784555 Free PMC article.
-
Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response.J Infect Dis. 2006 Mar 15;193(6):888-97. doi: 10.1086/500244. Epub 2006 Feb 9. J Infect Dis. 2006. PMID: 16479524 Free PMC article.
-
Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum.Infect Immun. 1994 Feb;62(2):680-4. doi: 10.1128/iai.62.2.680-684.1994. Infect Immun. 1994. PMID: 8300224 Free PMC article.
-
Evolution of the primary immune response to Histoplasma capsulatum in murine lung.Infect Immun. 1998 Apr;66(4):1473-81. doi: 10.1128/IAI.66.4.1473-1481.1998. Infect Immun. 1998. PMID: 9529070 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases